Results 191 to 200 of about 6,484,256 (294)

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

Molecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Emilie Brotin, Mélanie Briand, Enora Dolivet, Laurent Poulain, Marie Villedieu   +10 more
wiley   +1 more source

Fulminant and Slowly Progressive Type 1 Diabetes Associated with Pregnancy. [PDF]

Int J Mol Sci
Kawasaki E.
europepmc   +1 more source

On the Impact Value of the High Speed Steel of the Type 18:4:1

, 1943
川口 寅之輔
openalex   +2 more sources

Ultraviolet Inactivation of the Cytocidal and Transforming Activities of Human Adenovirus Type 1 [PDF]

, 1969
Jerry Z. Finklestein, Robert M. McAllister   +1 more
openalex   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

Pontocerebellar Hypoplasia Type 1 and Associated Neuronopathies. [PDF]

Genes (Basel)
Škarica M, Acsadi G, Živković SA.
europepmc   +1 more source

Measuring of CO<SUB>2</SUB>-percentages in Flue-gases with Nozzles (Part 1) : Critical-nozzle-type CO<SUB>2</SUB> meter with Chemical-absorbent

, 1951
Naotsugu MASUGI
openalex   +2 more sources

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Management of dyslipidaemia in patients with comorbidities-facing the challenge: type 1 diabetes mellitus. [PDF]

Eur Heart J Cardiovasc Pharmacother
Kaser S, Dobrev D, Rocca B, Kaski JC, Agewall S, Drexel H.   +5 more
europepmc   +1 more source

Studies on Corrosion at Hydro-electric Plants Using Acid River Water (1st Report). Studies on Corrosion of Metals (Part 1) Districts Incurring Corrosion Damage and Types of Damage

, 1951
Hikozô Endô, S. Ishihara, Yoshinobu Sawada   +2 more
openalex   +2 more sources